Answers are grounded in this paper and cite their sources.
This study explored the bioactive potential of Plectranthus amboinicus essential oil (PAEO) and its nanoemulsion (PANE). PAEO, extracted via hydro-distillation, contained 71.3 % carvacrol (GC–MS). PANE exhibited a Z-average diameter of 200.3 nm, ζ-potential of -9.54 mV, and FT-IR-confirmed encapsulation. Although PAEO showed larger antimicrobial zones (20–23 mm) against S. aureus and E. coli , PANE demonstrated lower MICs (96 μ L/mL vs. >96 μ L/mL). PANE was better than PAEO in controlling obesity, with enhanced lipid peroxidation inhibition ( IC₅₀ : 147.91 vs. 189.47 μ L) and DPPH radical scavenging ( IC₅₀ :115.47–140.21 vs. 203.38 μ L). PANE ( IC₅₀ : 350.00 μ L) showed reduced lipase inhibition versus crude form (163.23 μ L) due to encapsulation. MTT assays revealed PANE’s enhanced bioavailability ( IC₅₀ : 1 ± 0.01 μ L PANE vs. 2.5 ± 0.01 μ L PAEO), supporting adipocyte gene modulation. PAEO induced stronger PRDM16 up-regulation (5.03-fold, p = 0.001), a key adipocyte browning marker, but pungency and instability limits therapeutic utility. In contrast, PANE, a stable nanoemulsion, achieved significant PRDM16 activation (3.91-fold, p = 0.006) without stability concerns, positioning it as a viable phytochemical alternative to Orlistat in obesity management.
No takes yet. Share an insight, caveat, or question.
Shruthi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: